1
|
Walling AM, Wenger NS, Chau AJ, Reihm J, Gibbs L, Rahimi M, Hays RD, Sudore RL. Standard HIPAA Authorization Forms Decreased Response Rates for a Multi-site Pragmatic Trial. J Gen Intern Med 2025; 40:1150-1156. [PMID: 39438380 PMCID: PMC11968583 DOI: 10.1007/s11606-024-09074-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/16/2024] [Accepted: 09/21/2024] [Indexed: 10/25/2024]
Abstract
BACKGROUND The Health Insurance Portability and Accountability Act (HIPAA) aims to safeguard patient information; however, complex legal language may lead to confusion and mistrust, and hinder enrollment in clinical trials. OBJECTIVE To evaluate the effect of a standard HIPAA authorization included in mailed survey packets on study enrollment for a multi-site pragmatic trial. DESIGN This study is nested within an advance care planning pragmatic trial at 50 primary care clinics across three University of California (UC) Health Systems. PARTICIPANTS We included English and Spanish-speaking seriously ill patients. INTERVENTIONS One third of eligible patients received and 2/3 did not receive the HIPAA authorization in their enrollment packet. MAIN MEASURES We compared enrollment rates at 3 months and assessed the readability, understandability, and actionability of the standard HIPAA form using the Federal Plain Language Guidelines Checklist for Plain Language, the Automatic Readability Checker consensus calculator (grade 8 is the average reading level for US adults), and the Patient Education Materials Assessment Tool for Printable Materials (PEMAT-P, 0-100%, 70% considered the minimum). KEY RESULTS Of 4632 eligible patients (mean age 71, 48% women, 11% Spanish-speaking, 40% racial/ethnic minority); 1543 received a mailed enrollment packet with a HIPAA form and 3089 did not. Patients mailed the HIPAA form were less likely to enroll (10.2% vs. 14.8%, p < 0.001). The standard HIPAA form scored at the 12th grade reading level, had a PEMAT-P Understandability score of 42%, had an Actionability score of 40%, and only met 50% of Federal Plain Language Guideline Checklist items. CONCLUSIONS The inclusion of a standard HIPAA authorization in mailed enrollment packets for a large pragmatic trial led to lower rates of study enrollment. This study informs how HIPAA authorization forms should be redesigned to be more accessible to patients to prevent unnecessary barriers to research enrollment.
Collapse
Affiliation(s)
- Anne M Walling
- Department of Medicine, University of California, Los Angeles, Los Angeles, CA, USA.
- VA Greater Los Angeles Health System, Los Angeles, CA, USA.
| | - Neil S Wenger
- Department of Medicine, University of California, Los Angeles, Los Angeles, CA, USA
| | - Aaron J Chau
- Division of Geriatric Medicine, Department of Family Medicine, University of California, Irvine School of Medicine, Irvine, CA, USA
| | - Jennifer Reihm
- Division of Rheumatology, University of California, San Francisco, San Francisco, CA, USA
| | - Lisa Gibbs
- Division of Geriatric Medicine, Department of Family Medicine, University of California, Irvine School of Medicine, Irvine, CA, USA
| | - Maryam Rahimi
- Department of Medicine, University of California, Irvine, Irvine, CA, USA
| | - Ron D Hays
- Department of Medicine, University of California, Los Angeles, Los Angeles, CA, USA
| | - Rebecca L Sudore
- Division of Geriatrics, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA
- San Francisco VA Medical Center, San Francisco, CA, USA
| |
Collapse
|
2
|
Russo F, Sherburn I, Finlay K, Nunn J, Ferrie M, McKenzie A, Murray S, Cannings J, Pratt G, Boughtwood T. "I just don't know enough": Australian perspectives on community involvement in health and medical research. RESEARCH INVOLVEMENT AND ENGAGEMENT 2024; 10:126. [PMID: 39609924 PMCID: PMC11603817 DOI: 10.1186/s40900-024-00633-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/20/2024] [Accepted: 09/10/2024] [Indexed: 11/30/2024]
Abstract
BACKGROUND There is increasing global support from governments and other funding bodies for community involvement in research, alongside a scientific and moral imperative for responsible and ethical research practice. Ninety per cent of Australian patient-led organisations in rare diseases have clearly articulated research priorities, indicating a desire among people affected by disease to be involved in research that impacts their communities. Philanthropic research, which is likely to have predominantly community-minded priorities, is worth over AU$1 billion annually and increased more than 100% between 2007 and 2017. AIMS This research aimed to understand public perspectives on community involvement in health-related research activities, and to inform the development of guidelines for genomic researchers to improve this involvement. METHODS A 37-question survey was completed by 1,156 members of the Australian public via Dynata. The survey was co-designed by the Involve Australia Working Group of community members within Australian Genomics. Results from 1156 responses were analysed. RESULTS Key themes emerging from the survey data that impact potential involvement were low community confidence to contribute, a limited understanding of community involvement, roles and recognition, trust and governance of data, perceived trustworthiness of research funders, and factors related to time and personal resources. A variety of motivations for involvement were also stated. CONCLUSION Members of the Australian public are interested in research involvement; however the differences between involvement and participation are poorly understood and a variety of barriers still exist. Researchers must actively reach out into communities and offer opportunities to engage with research and identify community priorities.
Collapse
Affiliation(s)
- Fiona Russo
- Centre for Health Research, University of Southern Queensland, Toowoomba, QLD, Australia.
| | - Isabella Sherburn
- Australian Genomics, Murdoch Children's Research Institute, Melbourne, VIC, Australia
| | - Keri Finlay
- Australian Genomics, Murdoch Children's Research Institute, Melbourne, VIC, Australia
| | - Jack Nunn
- Science for All, Melbourne, VIC, Australia
| | - Monica Ferrie
- Genetic Support Network of Victoria, Melbourne, VIC, Australia
| | | | - Sean Murray
- Community Advisory Group, Australian Genomics, Melbourne, VIC, Australia
- Mito Foundation, Sydney, NSW, Australia
| | - John Cannings
- Community Advisory Group, Australian Genomics, Melbourne, VIC, Australia
| | - Greg Pratt
- Office of Indigenous Engagement, Central Queensland University, Rockhampton North, QLD, Australia
| | - Tiffany Boughtwood
- Australian Genomics, Murdoch Children's Research Institute, Melbourne, VIC, Australia
| |
Collapse
|
3
|
Pal A, Arnet I, Elger BS, Wangmo T. Practices and Barriers in Developing and Disseminating Plain-Language Resources Reporting Medical Research Information: A Scoping Review. THE PATIENT 2024; 17:493-518. [PMID: 38878237 PMCID: PMC11343906 DOI: 10.1007/s40271-024-00700-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Accepted: 05/12/2024] [Indexed: 08/24/2024]
Abstract
BACKGROUND The intent of plain-language resources (PLRs) reporting medical research information is to advance health literacy among the general public and enable them to participate in shared decision-making (SDM). Regulatory mandates coupled with academic and industry initiatives have given rise to an increasing volume of PLRs summarizing medical research information. However, there is significant variability in the quality, format, readability, and dissemination channels for PLRs. In this scoping review, we identify current practices, guidance, and barriers in developing and disseminating PLRs reporting medical research information to the general public including patients and caregivers. We also report on the PLR preferences of these intended audiences. METHODS A literature search of three bibliographic databases (PubMed, EMBASE, Web of Science) and three clinical trial registries (NIH, EMA, ISRCTN registry) was performed. Snowball searches within reference lists of primary articles were added. Articles with PLRs or reporting topics related to PLRs use and development available between January 2017 and June 2023 were identified. Evidence mapping and synthesis were used to make qualitative observations. Identified PLRs were quantitatively assessed, including temporal annual trends, availability by field of medicine, language, and publisher types. RESULTS A total of 9116 PLRs were identified, 9041 from the databases and 75 from clinical trial registries. The final analysis included 6590 PLRs from databases and 72 from registries. Reported barriers to PLR development included ambiguity in guidance, lack of incentives, and concerns of researchers writing for the general public. Available guidance recommendations called for greater dissemination, increased readability, and varied content formats. Patients preferred visual PLRs formats (e.g., videos, comics), which were easy to access on the internet and used short jargon-free text. In some instances, older audiences and more educated readers preferred text-only PLRs. Preferences among the general public were mostly similar to those of patients. Psychology, followed by oncology, showed the highest number of PLRs, predominantly from academia-sponsored research. Text-only PLRs were most commonly available, while graphical, digital, or online formats were less available. Preferred dissemination channels included paywall-free journal websites, indexing on PubMed, third-party websites, via email to research participants, and social media. CONCLUSIONS This scoping review maps current practices, recommendations, and patients' and the general public's preferences for PLR development and dissemination. The results suggest that making PLRs available to a wider audience by improving nomenclature, accessibility, and providing translations may contribute to empowerment and SDM. Minimizing variability among available guidance for PLR development may play an important role in amplifying the value and impact of these resources.
Collapse
Affiliation(s)
- Avishek Pal
- Institute of Biomedical Ethics, University of Basel, Bernouillistrasse 28, 4056, Basel, Switzerland.
| | - Isabelle Arnet
- Pharmaceutical Care Research Group, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland
| | - Bernice Simone Elger
- Institute of Biomedical Ethics, University of Basel, Bernouillistrasse 28, 4056, Basel, Switzerland
- University Center of Legal Medicine (CURML), University of Geneva, Geneva, Switzerland
| | - Tenzin Wangmo
- Institute of Biomedical Ethics, University of Basel, Bernouillistrasse 28, 4056, Basel, Switzerland
| |
Collapse
|
4
|
Pal A, Klingmann I, Wangmo T, Elger B. Publishing clinical trial results in plain language: a clash of ethical principles? Curr Med Res Opin 2024; 40:493-503. [PMID: 38354123 DOI: 10.1080/03007995.2024.2308729] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/26/2023] [Accepted: 01/18/2024] [Indexed: 02/16/2024]
Abstract
Plain language resources (PLR) are lay summaries of clinical trial results or plain language summaries of publications, in digital/visual/language formats. They aim to provide accurate information in jargon-free, and easy-to-understand language that can meet the health information needs of the general public, especially patients and caregivers. These are typically developed by the study sponsors or investigators, or by national public health bodies, research hospitals, patient organizations, and non-profit organizations. While the usefulness of PLR seems unequivocal, they have never been analyzed from the perspective of ethics. In this commentary, we do so and reflect on whether PLR are categorically advantageous or if they solve certain issues but raise new problems at the same time. Ethical concerns that PLR can potentially address include but are not limited to individual and community level health literacy, patient empowerment and autonomy. We also highlight the ethical issues that PLR may potentially exacerbate, such as fair balanced presentation and interpretation of medical knowledge, positive publication bias, and equitable access to information. PLR are important resources for patients, with promising implications for individual as well as community health. However, they require appropriate oversight and standards to optimize their potential value. Hence, we also highlight recommendations and best practices from our reading of the literature, that aim to minimize these biases.
Collapse
Affiliation(s)
- Avishek Pal
- Institute for Biomedical Ethics, University of Basel, Basel, Switzerland
| | - Ingrid Klingmann
- European Forum for Good Clinical Practice, Brussels, Belgium
- Pharmaplex BV, Brussels, Belgium
| | - Tenzin Wangmo
- Institute for Biomedical Ethics, University of Basel, Basel, Switzerland
| | - Bernice Elger
- Institute for Biomedical Ethics, University of Basel, Basel, Switzerland
| |
Collapse
|
5
|
Polidori P, Makridaki D, Kohl S. Clinical trials. Eur J Hosp Pharm 2024; 31:162-164. [PMID: 36931719 PMCID: PMC10895182 DOI: 10.1136/ejhpharm-2022-003471] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/19/2023] Open
Affiliation(s)
- Piera Polidori
- Hospital Pharmacy Complex Operational Unit, Azienda Ospedaliera Ospedali Riuniti Villa Sofia Cervello, Palermo, Italy
| | - Despina Makridaki
- Pharmacy Services, "Sismanoglio- Amalia Fleming", General Hospital of Attica, Athens, Greece
| | - Stephanie Kohl
- Policy & Advocacy, European Association of Hospital Pharmacists, Brussels, Belgium
| |
Collapse
|